論文発表

  • Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T.
    The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry.
    Eur J Neurol. 2013;20(6):921-7.
  • Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.
    Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    J Stroke Cerebrovasc Dis. 2013;22(8):e470-6.
  • Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T; FSR Investigators.
    Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry.
    BMJ Open.2013;3(11):e003678.
  • Makihara N, Kamouchi M, Hata J, Matsuo R, Ago T, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.
    Atherosclerosis. 2013;231(2):211-5.
  • Matsuo R, Ago T, Kamouchi M, Kuroda J, Kuwashiro T, Hata J, Sugimori H, Fukuda K, Gotoh S, Makihara N, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.
    Clinical significance of plasma VEGF value in ischemic stroke – research for biomarkers in ischemic stroke (REBIOS) study.
    BMC Neurol. 2013;13:32.
  • Tokami H, Ago T, Sugimori H, Kuroda J, Awano H, Suzuki K, Kiyohara Y, Kamouchi M, Kitazono T; REBIOS Investigators.
    RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke.
    Brain Res. 2013;1517:122-32.
  • Nakamura A, Ago T, Kamouchi M, Hata J, Matsuo R, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.
    Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry.
    Stroke. 2013;44(11):3239-42.